An observational study in Hospital Length of Stay, Step up Cases and Complication Postoperative, sponsored by Indonesia University. Recruiting at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.
Sponsored by Indonesia University · Observational
To determine the effectiveness of postoperative hospital length of stay and the number of ICU or HCU step-up cases among elective postoperative patients observed in the PACU and HCU.
1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.
This study's planned enrollment of 386 is above the median of 251 across 537 observational studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →Indonesia University is the lead sponsor of 446 studies on the registry; 56 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients undergoing elective surgery at RSCM who receive postoperative observation in the PACU or HCU.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing elective surgery in the Kanigara operating room with postoperative observation directly from the operating room to the HCU.
Patients undergoing elective surgery in the Kanigara operating room with postoperative observation directly from the operating room to the PACU.
number of ICU or HCU step-up cases
Patients receiving care in the general ward, surgical HCU, or PACU after elective surgery in the Kanigara operating room who experience clinical deterioration requiring admission to the ICU or HCU according to the ICU or HCU admission criteria at RSCM.
Time frame: from the day of surgery until the patient is discharged from the hospital or the patient dies up to 30 days
postoperative hospital length of stay
The duration of postoperative care is calculated from the day of surgery until the patient is discharged from the hospital or dies.
Time frame: from the day of surgery until the patient is discharged from the hospital or the patient dies up to 30 days
Started May 2026 (actual). Primary completion is estimated for Oct 2026, 5 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 5 months is below that.
Counting every sponsor, half of 281 studies reached it within 23 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.